Treatment of hidradenitis suppurativa by photodynamic therapy with aminolevulinic acid: Preliminary results

Journal of Drugs in Dermatology

Volumn 10, Issue 4, 2011, Pages 381-386

  Schweiger, Eric S ^a   Riddle, Christy C ^b   Aires, Daniel J ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT;

ADULT; APPLICATION SITE HYPERPIGMENTATION; ARTICLE; BLISTER; BLUE LIGHT; BURN; CLINICAL ARTICLE; CLINICAL TRIAL; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GLOBAL SEVERITY SCORE; HUMAN; HYPERPIGMENTATION; INTENSE PULSED LIGHT; INTERMETHOD COMPARISON; LIGHT; MALE; OPEN STUDY; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; QUALITY OF LIFE; SCAR; SCORING SYSTEM; SKIN BRUISING; SUPPURATIVE HIDRADENITIS; TREATMENT OUTCOME; HEALTH CARE QUALITY; MIDDLE AGED; PHOTOCHEMOTHERAPY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AMINOLEVULINIC ACID; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; QUALITY OF LIFE; STANDARD OF CARE; TREATMENT OUTCOME;

EID: 79960247795     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Yu CC, Cook MG. Hidradenitis suppurativa: A disease of follicular epithelium, rather than apocrine glands. Br J Dermatol. 1990;122:763-769. (Pubitemid 20182193)
2. Strauss RM, Pollock B, Stables GI, Goulden V, Cunliffe WJ. Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol. 2005;152:803-804. (Pubitemid 40571321)
3. Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35:191-194.
4. Ather S, Chan DS, Leaper DJ, Harding KG. Surgical treatment of hidradenitis suppurativa: Case series and review of the literature. Int Wound J. 2006;3:159-169.
5. Gold MH. Aminolevulinic acid photodynamic therapy for hidradenitis suppurativa. Dermatol Clin. 2007;25:67-73. (Pubitemid 44780057)
6. Meixner D, Schneider S, Krause M, Sterry W. Acne inverse. J Dtsch Dermatol Ges. 2008;6:189-196. Epub 2007.
7. Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS. Infliximab for hidradenitis suppurativa. Br J Dermatol. 2003;149:1046-1049. (Pubitemid 37541993)
8. Joseph MA, Jayaseelan E, Ganapathi B, Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat. 2005;16:75-78. (Pubitemid 40676905)
9. Lebwohl B, Sapadin AN. Infliximab for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2003;49(suppl):s275-s276. (Pubitemid 37314860)
10. Rosi YL, Lowe L, Kang S. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease. J Dermatol Treat. 2005;16:58-61. (Pubitemid 40283328)
11. Cusack C, Buckley C. Etanercept effective in the management of hidradenitis suppurativa. Br J Dermatol. 2006;154:726-729. (Pubitemid 43374099)
12. Moul DK, Korman NJ. The cutting edge. Severe hidradenitis suppurative treated with adalimumab. Arch Dermatol. 2006;142:1110-1112. (Pubitemid 44414393)
13. Strober BE, Kim C, Siu K. Efalizumab for the treatment of refractory hidradenitis suppurativa. J Am Acad Dermatol. 2007;57:1090-1091. (Pubitemid 350087344)
14. Gold M, Bridges TM, Bradshaw VL, Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol. 2004;3(suppl):32S-35S.
15. Von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001;144:809-813. (Pubitemid 32374785)
16. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183-192. (Pubitemid 30637186)
17. Nestor MS, Gold MH, Kauvar AN et al. The use of photodynamic therapy in dermatology: Results of a consensus conference. J Drugs Dermatol. 2006;5:140-154.
18. Itoh Y, Ninomiya Y, Tajima S, et al. Photodynamic Therapy of Acne Vulgaris With Topical Delta-Aminolevulinic Acid and Incoherent Light in Japanese Patients. Br J Dermatol. 2001;144:575-579. (Pubitemid 32232014)
19. McAnnally AK, Dockerty MB. Carcinoma developing in chronic draining cutaneous sinuses and fistulas. Surg Gynecol Obstet. 1949;88:87-96.
20. Donsky HJ, Mendelson CG. Squamous Cell Carcinoma as a complication of hidradenitis suppurativa. Arch Dermatol. 1964;90:488-491.
21. Humphrey LJ, Playforth H, Leavell UW Jr. Squamous cell carcinoma arising in hidradenitis suppurativum. Arch Dermatol. 1969;100:59-62.
22. Alexander SJ. Squamous cell carcinoma in chronic hydradenitis suppurativa: A case report. Cancer. 1979;43:745-748. (Pubitemid 9129116)
23. Zachary LS, Robson MC, Rachmaninoff N. Squamous cell carcinoma occurring in hidradenitis suppurativa. Ann Plast Surg. 1987;18:71-73. (Pubitemid 17004276)
24. Anstey AV, Wilkinson JD, Lord P. Squamous cell carcinoma complicating hidradenitis suppurativa. Br J Dermatol. 1990;123:527-531. (Pubitemid 20344795)
25. Mendonça H, Rebelo C, Fernandes A et al. Squamous cell carcinoma arising in hidradenitis suppurativa. J Dermatol Surg Oncol. 1991;17:830-832.
26. Malaguarnera M, Pontillo T, Pistone G, Succi L. Squamous-cell cancer in Verneuil's disease (hidradenitis suppurativa) Lancet. 1996;348:1449. (Pubitemid 26395248)
27. Dufresne RG Jr, Ratz JL, Bergfeld WF, Roenigk RK. Squamous cell carcinoma arising from the follicular occlusion triad. J Am Acad Dermatol. 1996;35:475-477. (Pubitemid 26299245)
28. Bissonnette R. Chemopreventive thoughts for photodynamic therapy. Dermatol Clin. 2007;25:95-100.
29. Kalisiak M S, Rao J. Photodynamic therapy for actinic keratoses. Dermatol Clin. 2007;25:15-23. (Pubitemid 44780060)
30. Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for skin cancers. Dermatol Clin. 2007;25:5-14. (Pubitemid 44794580)
31. Fien SM, Oseroff AR. Photodynamic therapy for non-melanoma skin cancer. J Natl Compr Canc Netw. 2007;5:531-534.